 Leslie Berg
Concepts (515)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein-Tyrosine Kinases | 60 | 2021 | 431 | 10.060 |
Why?
| | T-Lymphocytes | 46 | 2022 | 2007 | 3.900 |
Why?
| | Receptors, Antigen, T-Cell | 41 | 2024 | 720 | 3.830 |
Why?
| | CD8-Positive T-Lymphocytes | 22 | 2020 | 918 | 3.670 |
Why?
| | Signal Transduction | 51 | 2024 | 5169 | 3.170 |
Why?
| | Cell Differentiation | 41 | 2017 | 2006 | 3.160 |
Why?
| | Lymphocyte Activation | 32 | 2024 | 1150 | 3.030 |
Why?
| | CD4-Positive T-Lymphocytes | 25 | 2016 | 1115 | 2.430 |
Why?
| | Interferon Regulatory Factors | 5 | 2020 | 46 | 2.050 |
Why?
| | Lymphocytic choriomeningitis virus | 7 | 2017 | 33 | 1.900 |
Why?
| | Thymus Gland | 24 | 2014 | 319 | 1.750 |
Why?
| | T-Lymphocyte Subsets | 13 | 2014 | 415 | 1.310 |
Why?
| | Mice | 90 | 2022 | 18109 | 1.300 |
Why?
| | Mice, Knockout | 31 | 2020 | 3071 | 1.280 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 11 | 2017 | 335 | 1.210 |
Why?
| | Animals | 110 | 2024 | 37749 | 1.170 |
Why?
| | Janus Kinase 3 | 16 | 2009 | 18 | 1.080 |
Why?
| | Intestines | 3 | 2020 | 357 | 1.060 |
Why?
| | Lymphocytic Choriomeningitis | 4 | 2015 | 22 | 1.010 |
Why?
| | Lymphocytes | 5 | 2019 | 398 | 0.990 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 7 | 2014 | 101 | 0.970 |
Why?
| | Mice, Inbred C57BL | 40 | 2020 | 5909 | 0.930 |
Why?
| | Proto-Oncogene Proteins c-vav | 1 | 2024 | 2 | 0.880 |
Why?
| | Th1 Cells | 4 | 2015 | 139 | 0.880 |
Why?
| | T-Box Domain Proteins | 6 | 2015 | 102 | 0.840 |
Why?
| | Immunologic Memory | 8 | 2017 | 360 | 0.830 |
Why?
| | Mice, Transgenic | 32 | 2015 | 2184 | 0.800 |
Why?
| | Cell Proliferation | 7 | 2020 | 2506 | 0.770 |
Why?
| | Interleukin Receptor Common gamma Subunit | 3 | 2019 | 14 | 0.760 |
Why?
| | Chemotaxis, Leukocyte | 3 | 2020 | 145 | 0.760 |
Why?
| | Cells, Cultured | 16 | 2021 | 4212 | 0.740 |
Why?
| | Flow Cytometry | 16 | 2022 | 1197 | 0.700 |
Why?
| | Arenaviridae Infections | 3 | 2017 | 17 | 0.670 |
Why?
| | Autoimmune Diseases | 2 | 2024 | 465 | 0.660 |
Why?
| | CD4 Antigens | 9 | 2007 | 141 | 0.660 |
Why?
| | Killer Cells, Natural | 5 | 2014 | 471 | 0.630 |
Why?
| | Calcium | 3 | 2022 | 1192 | 0.620 |
Why?
| | Transcription Factors | 11 | 2016 | 1712 | 0.580 |
Why?
| | Cytokines | 7 | 2009 | 2100 | 0.570 |
Why?
| | Natural Killer T-Cells | 3 | 2014 | 67 | 0.550 |
Why?
| | Kruppel-Like Transcription Factors | 3 | 2014 | 67 | 0.550 |
Why?
| | Influenza A virus | 3 | 2016 | 111 | 0.540 |
Why?
| | Orthomyxoviridae Infections | 2 | 2016 | 68 | 0.530 |
Why?
| | Colitis | 2 | 2019 | 266 | 0.500 |
Why?
| | Th2 Cells | 3 | 2009 | 177 | 0.500 |
Why?
| | Interleukin-2 | 9 | 2019 | 456 | 0.500 |
Why?
| | Enhancer Elements, Genetic | 2 | 2017 | 189 | 0.480 |
Why?
| | Molecular Sequence Data | 21 | 2015 | 2929 | 0.440 |
Why?
| | Models, Immunological | 5 | 2012 | 101 | 0.440 |
Why?
| | Amino Acid Sequence | 19 | 2015 | 2158 | 0.430 |
Why?
| | Repressor Proteins | 1 | 2017 | 430 | 0.420 |
Why?
| | NFATC Transcription Factors | 6 | 2021 | 94 | 0.420 |
Why?
| | CD28 Antigens | 5 | 2013 | 58 | 0.420 |
Why?
| | Nuclear Proteins | 4 | 2003 | 719 | 0.400 |
Why?
| | Interferon-gamma | 6 | 2016 | 792 | 0.400 |
Why?
| | Ephrins | 2 | 2002 | 8 | 0.390 |
Why?
| | Receptor-CD3 Complex, Antigen, T-Cell | 3 | 2001 | 9 | 0.390 |
Why?
| | Gene Expression Regulation | 7 | 2021 | 2608 | 0.390 |
Why?
| | Inflammation | 1 | 2024 | 2902 | 0.390 |
Why?
| | Allergy and Immunology | 1 | 2012 | 41 | 0.370 |
Why?
| | Histocompatibility Antigens Class I | 4 | 2010 | 209 | 0.370 |
Why?
| | Membrane Proteins | 4 | 2015 | 1158 | 0.370 |
Why?
| | Phosphorylation | 11 | 2018 | 1774 | 0.360 |
Why?
| | Protein Kinase Inhibitors | 2 | 2015 | 919 | 0.360 |
Why?
| | Antigens, CD | 6 | 2016 | 545 | 0.350 |
Why?
| | Interleukin-4 | 5 | 2014 | 215 | 0.350 |
Why?
| | Epigenesis, Genetic | 2 | 2013 | 663 | 0.340 |
Why?
| | Cellular Senescence | 1 | 2013 | 206 | 0.330 |
Why?
| | Phospholipase C gamma | 5 | 2018 | 28 | 0.330 |
Why?
| | Thymocytes | 3 | 2014 | 35 | 0.310 |
Why?
| | Adoptive Transfer | 3 | 2020 | 223 | 0.310 |
Why?
| | Proto-Oncogene Proteins c-abl | 1 | 2008 | 6 | 0.300 |
Why?
| | X-Linked Combined Immunodeficiency Diseases | 1 | 2008 | 2 | 0.300 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2009 | 136 | 0.300 |
Why?
| | Major Histocompatibility Complex | 5 | 1997 | 234 | 0.300 |
Why?
| | Apoptosis | 6 | 2014 | 2576 | 0.290 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2010 | 231 | 0.280 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2013 | 391 | 0.280 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2019 | 150 | 0.280 |
Why?
| | Phosphoproteins | 2 | 2001 | 338 | 0.280 |
Why?
| | Interleukin-15 | 4 | 2014 | 101 | 0.270 |
Why?
| | src-Family Kinases | 3 | 2018 | 94 | 0.270 |
Why?
| | src Homology Domains | 5 | 2003 | 38 | 0.270 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2008 | 103 | 0.270 |
Why?
| | Tyrosine | 4 | 2013 | 228 | 0.270 |
Why?
| | CD8 Antigens | 6 | 2007 | 76 | 0.270 |
Why?
| | Immunoglobulin E | 1 | 2009 | 331 | 0.270 |
Why?
| | Cell Lineage | 7 | 2015 | 352 | 0.260 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 389 | 0.260 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 3 | 2014 | 8 | 0.250 |
Why?
| | Cell Cycle | 1 | 2009 | 600 | 0.250 |
Why?
| | Receptors, Eph Family | 2 | 2002 | 6 | 0.250 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2016 | 226 | 0.250 |
Why?
| | Antigens, Differentiation | 3 | 2004 | 83 | 0.240 |
Why?
| | Lymphopenia | 2 | 2008 | 67 | 0.240 |
Why?
| | B-Lymphocytes | 4 | 2009 | 859 | 0.230 |
Why?
| | Mast Cells | 1 | 2007 | 153 | 0.230 |
Why?
| | Humans | 39 | 2024 | 141754 | 0.220 |
Why?
| | Autoimmunity | 2 | 2024 | 908 | 0.220 |
Why?
| | Antigens, CD1d | 2 | 2014 | 68 | 0.220 |
Why?
| | Up-Regulation | 6 | 2014 | 860 | 0.210 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 987 | 0.210 |
Why?
| | Ligands | 8 | 2009 | 667 | 0.210 |
Why?
| | Gene Expression | 5 | 2014 | 1492 | 0.210 |
Why?
| | Enzyme Activation | 6 | 2010 | 811 | 0.200 |
Why?
| | Receptor, EphA1 | 1 | 2002 | 2 | 0.200 |
Why?
| | Receptors, Lymphocyte Homing | 2 | 2020 | 16 | 0.200 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2002 | 368 | 0.190 |
Why?
| | Homeostasis | 3 | 2013 | 636 | 0.190 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 326 | 0.190 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 98 | 0.190 |
Why?
| | Down-Regulation | 3 | 2010 | 641 | 0.190 |
Why?
| | Histocompatibility Antigens Class II | 4 | 1999 | 369 | 0.190 |
Why?
| | Cytoplasm | 2 | 2022 | 273 | 0.190 |
Why?
| | Membrane Glycoproteins | 2 | 2002 | 502 | 0.190 |
Why?
| | Interleukin-17 | 3 | 2013 | 119 | 0.190 |
Why?
| | Stomach Neoplasms | 1 | 2024 | 118 | 0.190 |
Why?
| | Cell Line | 7 | 2015 | 2887 | 0.190 |
Why?
| | Jurkat Cells | 6 | 2009 | 138 | 0.190 |
Why?
| | Type C Phospholipases | 4 | 2003 | 73 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2004 | 876 | 0.180 |
Why?
| | Immunophenotyping | 5 | 2016 | 329 | 0.180 |
Why?
| | NF-kappa B | 2 | 2021 | 692 | 0.180 |
Why?
| | H-2 Antigens | 3 | 2014 | 115 | 0.180 |
Why?
| | CD3 Complex | 2 | 2009 | 106 | 0.180 |
Why?
| | Promoter Regions, Genetic | 4 | 2014 | 1243 | 0.180 |
Why?
| | Stem Cells | 3 | 2001 | 603 | 0.170 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 420 | 0.170 |
Why?
| | Male | 17 | 2021 | 70179 | 0.170 |
Why?
| | Polymerase Chain Reaction | 4 | 2017 | 1056 | 0.170 |
Why?
| | Receptors, Immunologic | 1 | 2002 | 215 | 0.170 |
Why?
| | Hematopoiesis | 4 | 2010 | 194 | 0.170 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 3 | 2016 | 17 | 0.160 |
Why?
| | Tacrolimus | 1 | 2001 | 198 | 0.160 |
Why?
| | Hematopoietic Stem Cells | 4 | 1999 | 411 | 0.160 |
Why?
| | Rhadinovirus | 1 | 2020 | 20 | 0.160 |
Why?
| | History, 21st Century | 2 | 2012 | 220 | 0.160 |
Why?
| | Protein Binding | 6 | 2018 | 2242 | 0.150 |
Why?
| | History, 20th Century | 2 | 2012 | 330 | 0.150 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 4 | 2016 | 97 | 0.150 |
Why?
| | Spleen | 4 | 2014 | 525 | 0.150 |
Why?
| | Immunoconjugates | 1 | 2001 | 125 | 0.150 |
Why?
| | Cricetinae | 3 | 2015 | 301 | 0.150 |
Why?
| | Receptors, Cytokine | 1 | 1999 | 36 | 0.150 |
Why?
| | Sea Urchins | 2 | 1998 | 7 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2000 | 439 | 0.150 |
Why?
| | Interleukin-33 | 1 | 2019 | 50 | 0.150 |
Why?
| | Blood Proteins | 1 | 2001 | 250 | 0.150 |
Why?
| | Hepatocyte Nuclear Factor 1-alpha | 2 | 2015 | 20 | 0.140 |
Why?
| | Base Sequence | 7 | 1997 | 2180 | 0.140 |
Why?
| | Chronic Disease | 1 | 2024 | 1820 | 0.140 |
Why?
| | DNA-Binding Proteins | 5 | 2006 | 1485 | 0.140 |
Why?
| | DNA | 3 | 2021 | 1444 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 6 | 2001 | 674 | 0.130 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 136 | 0.130 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily C | 1 | 2016 | 8 | 0.130 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1997 | 72 | 0.130 |
Why?
| | Peptide Fragments | 4 | 1997 | 701 | 0.130 |
Why?
| | Virus Replication | 1 | 2020 | 532 | 0.130 |
Why?
| | Clonal Deletion | 4 | 2001 | 16 | 0.130 |
Why?
| | Phenotype | 5 | 2006 | 3177 | 0.130 |
Why?
| | Seals, Earless | 2 | 2006 | 5 | 0.120 |
Why?
| | Lymph Nodes | 2 | 2014 | 502 | 0.120 |
Why?
| | Hematopoietic System | 1 | 1996 | 8 | 0.120 |
Why?
| | Methylation | 2 | 2014 | 230 | 0.120 |
Why?
| | Mutation | 5 | 2013 | 4015 | 0.120 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 324 | 0.120 |
Why?
| | Mass Spectrometry | 1 | 2019 | 740 | 0.120 |
Why?
| | Biomarkers | 4 | 2024 | 4190 | 0.120 |
Why?
| | Chemokine CCL20 | 1 | 2015 | 5 | 0.120 |
Why?
| | Chemokine CXCL11 | 1 | 2015 | 3 | 0.120 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 515 | 0.120 |
Why?
| | Binding Sites | 7 | 2013 | 1316 | 0.120 |
Why?
| | Introns | 1 | 1997 | 254 | 0.120 |
Why?
| | Receptors, Interleukin-7 | 3 | 2001 | 27 | 0.120 |
Why?
| | Lymphoid Tissue | 1 | 1996 | 81 | 0.120 |
Why?
| | Exons | 1 | 1997 | 353 | 0.120 |
Why?
| | Germinal Center | 1 | 2015 | 66 | 0.110 |
Why?
| | Interferon Type I | 1 | 2016 | 141 | 0.110 |
Why?
| | Protein Structure, Tertiary | 4 | 2013 | 859 | 0.110 |
Why?
| | Transfection | 5 | 2001 | 943 | 0.110 |
Why?
| | Female | 16 | 2021 | 75943 | 0.110 |
Why?
| | Oligopeptides | 1 | 1996 | 275 | 0.110 |
Why?
| | Animal Structures | 1 | 2014 | 10 | 0.110 |
Why?
| | Cell Survival | 3 | 2014 | 1134 | 0.110 |
Why?
| | Th17 Cells | 1 | 2015 | 107 | 0.110 |
Why?
| | beta 2-Microglobulin | 1 | 2014 | 50 | 0.110 |
Why?
| | S100 Proteins | 1 | 2014 | 37 | 0.110 |
Why?
| | Annexin A2 | 1 | 2014 | 16 | 0.110 |
Why?
| | Prion Diseases | 1 | 1994 | 16 | 0.110 |
Why?
| | Spodoptera | 3 | 2010 | 40 | 0.110 |
Why?
| | Citalopram | 1 | 2014 | 35 | 0.100 |
Why?
| | Histone Deacetylase 2 | 1 | 2013 | 9 | 0.100 |
Why?
| | Cytochrome c Group | 4 | 2002 | 44 | 0.100 |
Why?
| | Cell Movement | 2 | 2013 | 990 | 0.100 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2013 | 28 | 0.100 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2014 | 66 | 0.100 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 80 | 0.100 |
Why?
| | Cell Migration Inhibition | 1 | 2013 | 17 | 0.100 |
Why?
| | Resting Phase, Cell Cycle | 2 | 2010 | 16 | 0.100 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 309 | 0.100 |
Why?
| | High Mobility Group Proteins | 1 | 2013 | 44 | 0.100 |
Why?
| | Lymphocyte Subsets | 1 | 2013 | 88 | 0.100 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2013 | 133 | 0.100 |
Why?
| | Animals, Newborn | 3 | 2006 | 870 | 0.090 |
Why?
| | Antidepressive Agents | 1 | 2014 | 254 | 0.090 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2013 | 135 | 0.090 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 200 | 0.090 |
Why?
| | Histones | 2 | 2014 | 639 | 0.090 |
Why?
| | Autoantigens | 2 | 2013 | 426 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 627 | 0.090 |
Why?
| | Acute Disease | 1 | 2014 | 1010 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2000 | 1178 | 0.090 |
Why?
| | Transcription, Genetic | 4 | 2015 | 1487 | 0.090 |
Why?
| | Monocytes | 1 | 2014 | 579 | 0.080 |
Why?
| | Alleles | 3 | 1995 | 891 | 0.080 |
Why?
| | Kinetics | 4 | 2013 | 1655 | 0.080 |
Why?
| | Transplantation Chimera | 1 | 2010 | 59 | 0.080 |
Why?
| | Isoenzymes | 2 | 2002 | 302 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 161 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2002 | 317 | 0.080 |
Why?
| | Mitosis | 1 | 2011 | 197 | 0.080 |
Why?
| | Interferon-beta | 1 | 2010 | 94 | 0.080 |
Why?
| | Phosphotyrosine | 2 | 2001 | 40 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2009 | 3495 | 0.080 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2012 | 394 | 0.080 |
Why?
| | Transcription Factors, TFII | 1 | 2009 | 44 | 0.080 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2010 | 101 | 0.080 |
Why?
| | Immunoglobulin Class Switching | 1 | 2009 | 21 | 0.080 |
Why?
| | Apnea | 2 | 2006 | 22 | 0.080 |
Why?
| | T-Lymphocytes, Cytotoxic | 3 | 1996 | 174 | 0.080 |
Why?
| | DNA, Complementary | 4 | 2001 | 274 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 196 | 0.070 |
Why?
| | Herpesvirus 2, Human | 1 | 2009 | 29 | 0.070 |
Why?
| | Rats | 2 | 2014 | 5637 | 0.070 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 49 | 0.070 |
Why?
| | Xenopus Proteins | 2 | 2006 | 37 | 0.070 |
Why?
| | GPI-Linked Proteins | 1 | 2009 | 78 | 0.070 |
Why?
| | Antigen-Presenting Cells | 2 | 2002 | 159 | 0.070 |
Why?
| | Genes | 1 | 1988 | 229 | 0.070 |
Why?
| | STAT Transcription Factors | 1 | 2008 | 16 | 0.070 |
Why?
| | Structure-Activity Relationship | 2 | 2001 | 579 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 250 | 0.070 |
Why?
| | Societies, Medical | 1 | 2012 | 859 | 0.070 |
Why?
| | Atrophy | 1 | 2008 | 197 | 0.070 |
Why?
| | Herpes Simplex | 1 | 2009 | 95 | 0.070 |
Why?
| | STAT5 Transcription Factor | 1 | 2008 | 57 | 0.070 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 1997 | 21 | 0.070 |
Why?
| | Organ Culture Techniques | 2 | 2001 | 157 | 0.070 |
Why?
| | Herpesvirus 1, Human | 1 | 2009 | 81 | 0.070 |
Why?
| | Time Factors | 5 | 2010 | 6966 | 0.070 |
Why?
| | Conserved Sequence | 3 | 1998 | 238 | 0.070 |
Why?
| | Mice, Inbred C3H | 2 | 1999 | 270 | 0.070 |
Why?
| | CD5 Antigens | 2 | 2002 | 9 | 0.070 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2009 | 175 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 202 | 0.070 |
Why?
| | Clone Cells | 2 | 2001 | 267 | 0.070 |
Why?
| | HeLa Cells | 1 | 2009 | 640 | 0.070 |
Why?
| | CTLA-4 Antigen | 2 | 2013 | 103 | 0.070 |
Why?
| | Tissue Donors | 1 | 2010 | 406 | 0.070 |
Why?
| | Severe Combined Immunodeficiency | 2 | 1997 | 23 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 274 | 0.060 |
Why?
| | Antigens, Surface | 2 | 2014 | 156 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4421 | 0.060 |
Why?
| | Disease Susceptibility | 1 | 2008 | 353 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 855 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1997 | 377 | 0.060 |
Why?
| | Macromolecular Substances | 2 | 2001 | 226 | 0.060 |
Why?
| | Mice, Inbred BALB C | 5 | 2016 | 1275 | 0.060 |
Why?
| | Hyaluronan Receptors | 1 | 2006 | 103 | 0.060 |
Why?
| | Veins | 1 | 2006 | 70 | 0.060 |
Why?
| | Bone Marrow Cells | 3 | 2014 | 327 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2800 | 0.060 |
Why?
| | Lysine | 2 | 2014 | 292 | 0.060 |
Why?
| | Immunity, Innate | 2 | 2013 | 852 | 0.060 |
Why?
| | Cardiac Output | 1 | 2006 | 177 | 0.060 |
Why?
| | Transcriptome | 1 | 2012 | 1014 | 0.060 |
Why?
| | Lectins, C-Type | 2 | 2016 | 63 | 0.060 |
Why?
| | RNA, Messenger | 4 | 1998 | 2828 | 0.060 |
Why?
| | Point Mutation | 3 | 2010 | 237 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 73 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 82 | 0.060 |
Why?
| | Genetic Variation | 1 | 1990 | 1000 | 0.060 |
Why?
| | Recombinant Proteins | 3 | 1997 | 1363 | 0.050 |
Why?
| | Alternative Splicing | 2 | 1997 | 232 | 0.050 |
Why?
| | Protein Conformation | 3 | 2000 | 941 | 0.050 |
Why?
| | Molecular Structure | 1 | 2005 | 503 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 2 | 2005 | 624 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1094 | 0.050 |
Why?
| | Leukosialin | 2 | 2009 | 13 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 165 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2005 | 444 | 0.050 |
Why?
| | Signaling Lymphocytic Activation Molecule Family | 1 | 2002 | 7 | 0.050 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2002 | 85 | 0.050 |
Why?
| | Heart | 1 | 2006 | 620 | 0.050 |
Why?
| | Genes, T-Cell Receptor | 1 | 2002 | 9 | 0.050 |
Why?
| | Hybridomas | 2 | 2000 | 236 | 0.050 |
Why?
| | Fas Ligand Protein | 1 | 2002 | 60 | 0.050 |
Why?
| | ZAP-70 Protein-Tyrosine Kinase | 1 | 2001 | 10 | 0.050 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2001 | 10 | 0.050 |
Why?
| | Cysteine | 2 | 2001 | 208 | 0.050 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 227 | 0.040 |
Why?
| | Transgenes | 1 | 2002 | 186 | 0.040 |
Why?
| | Fetus | 2 | 2012 | 802 | 0.040 |
Why?
| | Dimerization | 1 | 2001 | 196 | 0.040 |
Why?
| | Embryo, Nonmammalian | 2 | 2001 | 169 | 0.040 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 16 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2001 | 225 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2001 | 274 | 0.040 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2001 | 139 | 0.040 |
Why?
| | Injections, Intralymphatic | 1 | 2000 | 1 | 0.040 |
Why?
| | Abatacept | 1 | 2001 | 56 | 0.040 |
Why?
| | Mice, Congenic | 1 | 2000 | 23 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 2001 | 208 | 0.040 |
Why?
| | Calcium Signaling | 1 | 2003 | 250 | 0.040 |
Why?
| | Tumor Cells, Cultured | 3 | 1999 | 962 | 0.040 |
Why?
| | Cell Division | 2 | 2000 | 798 | 0.040 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2001 | 39 | 0.040 |
Why?
| | Androstadienes | 1 | 2001 | 78 | 0.040 |
Why?
| | Stromal Cells | 1 | 2001 | 117 | 0.040 |
Why?
| | Embryonic and Fetal Development | 1 | 2000 | 93 | 0.040 |
Why?
| | Granulocytes | 1 | 2000 | 85 | 0.040 |
Why?
| | Synovial Fluid | 1 | 2000 | 74 | 0.040 |
Why?
| | Detergents | 1 | 2000 | 45 | 0.040 |
Why?
| | Interphase | 1 | 1999 | 33 | 0.040 |
Why?
| | Enzyme Inhibitors | 2 | 2001 | 855 | 0.040 |
Why?
| | Cell Line, Transformed | 2 | 1999 | 145 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2001 | 310 | 0.040 |
Why?
| | Leukopoiesis | 1 | 1999 | 11 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 1999 | 36 | 0.040 |
Why?
| | Immune Tolerance | 2 | 1994 | 376 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 260 | 0.040 |
Why?
| | Blood Pressure | 1 | 2006 | 1748 | 0.040 |
Why?
| | Stem Cell Factor | 1 | 1999 | 17 | 0.040 |
Why?
| | Bone Marrow Transplantation | 1 | 2000 | 294 | 0.040 |
Why?
| | Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1998 | 8 | 0.040 |
Why?
| | Chemokines, CXC | 1 | 1999 | 71 | 0.040 |
Why?
| | Chemokine CXCL12 | 1 | 1999 | 84 | 0.040 |
Why?
| | Interleukin-7 | 1 | 1999 | 62 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2001 | 256 | 0.040 |
Why?
| | Biological Transport | 1 | 1999 | 410 | 0.040 |
Why?
| | Cricetulus | 2 | 2013 | 111 | 0.040 |
Why?
| | Ion Transport | 1 | 1998 | 62 | 0.040 |
Why?
| | Hyalin | 1 | 1998 | 5 | 0.040 |
Why?
| | Gene Rearrangement | 1 | 1999 | 151 | 0.030 |
Why?
| | Vanadates | 1 | 1997 | 17 | 0.030 |
Why?
| | Phosphopeptides | 1 | 1997 | 20 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 1997 | 167 | 0.030 |
Why?
| | Selection, Genetic | 2 | 1989 | 264 | 0.030 |
Why?
| | Molecular Weight | 2 | 1999 | 329 | 0.030 |
Why?
| | Receptors, Interleukin-2 | 2 | 1999 | 66 | 0.030 |
Why?
| | DNA Primers | 2 | 1995 | 510 | 0.030 |
Why?
| | Antibodies, Monoclonal | 3 | 1999 | 1474 | 0.030 |
Why?
| | Receptor, EphB6 | 1 | 1996 | 1 | 0.030 |
Why?
| | Species Specificity | 2 | 2006 | 583 | 0.030 |
Why?
| | Antigens, Neoplasm | 1 | 1999 | 322 | 0.030 |
Why?
| | Gene Deletion | 2 | 1999 | 389 | 0.030 |
Why?
| | Receptors, Interleukin | 1 | 1996 | 45 | 0.030 |
Why?
| | Agammaglobulinemia | 1 | 1996 | 36 | 0.030 |
Why?
| | Homozygote | 1 | 1997 | 201 | 0.030 |
Why?
| | Enzyme Induction | 1 | 1996 | 90 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 1996 | 59 | 0.030 |
Why?
| | Mice, SCID | 2 | 2013 | 367 | 0.030 |
Why?
| | Chickens | 1 | 1996 | 189 | 0.030 |
Why?
| | Poly I-C | 1 | 2016 | 64 | 0.030 |
Why?
| | Blotting, Western | 2 | 2013 | 1234 | 0.030 |
Why?
| | Receptors, CXCR5 | 1 | 2015 | 23 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2006 | 1757 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 748 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1995 | 533 | 0.030 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 90 | 0.030 |
Why?
| | Gene Targeting | 1 | 1995 | 83 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 133 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1996 | 363 | 0.030 |
Why?
| | Sialoglycoproteins | 1 | 1995 | 160 | 0.030 |
Why?
| | Organ Specificity | 1 | 1996 | 312 | 0.030 |
Why?
| | Feedback, Physiological | 1 | 2015 | 81 | 0.030 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2015 | 17 | 0.030 |
Why?
| | Consensus Sequence | 1 | 1995 | 74 | 0.030 |
Why?
| | Ovum | 1 | 1995 | 31 | 0.030 |
Why?
| | Ribonucleases | 1 | 1995 | 48 | 0.030 |
Why?
| | Lasers | 1 | 1995 | 130 | 0.030 |
Why?
| | Adult | 3 | 2014 | 39391 | 0.030 |
Why?
| | GTP Phosphohydrolases | 1 | 1995 | 93 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 1997 | 464 | 0.030 |
Why?
| | GTP-Binding Proteins | 1 | 1995 | 153 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2014 | 50 | 0.030 |
Why?
| | Stochastic Processes | 1 | 1994 | 70 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 1999 | 855 | 0.030 |
Why?
| | Epitopes | 1 | 1996 | 477 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 1995 | 287 | 0.030 |
Why?
| | Scrapie | 1 | 1994 | 3 | 0.030 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1994 | 21 | 0.030 |
Why?
| | PrPSc Proteins | 1 | 1994 | 9 | 0.030 |
Why?
| | Biomarkers, Pharmacological | 1 | 2014 | 26 | 0.030 |
Why?
| | CD4-CD8 Ratio | 1 | 1994 | 24 | 0.030 |
Why?
| | Dendritic Cells | 2 | 2015 | 505 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2006 | 498 | 0.030 |
Why?
| | Sf9 Cells | 1 | 2013 | 10 | 0.030 |
Why?
| | Deuterium Exchange Measurement | 1 | 2013 | 27 | 0.030 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1995 | 168 | 0.030 |
Why?
| | Prions | 1 | 1994 | 51 | 0.030 |
Why?
| | CHO Cells | 1 | 2013 | 168 | 0.030 |
Why?
| | Viral Proteins | 1 | 1996 | 369 | 0.030 |
Why?
| | Interferons | 1 | 2015 | 195 | 0.030 |
Why?
| | Natural Cytotoxicity Triggering Receptor 1 | 1 | 2013 | 3 | 0.030 |
Why?
| | SOXC Transcription Factors | 1 | 2013 | 5 | 0.030 |
Why?
| | Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 6 | 0.030 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2013 | 14 | 0.030 |
Why?
| | Biocatalysis | 1 | 2013 | 69 | 0.030 |
Why?
| | Cell Separation | 1 | 2014 | 317 | 0.030 |
Why?
| | Genes, abl | 1 | 1993 | 4 | 0.020 |
Why?
| | Genes, src | 1 | 1993 | 5 | 0.020 |
Why?
| | Antigens, Ly | 1 | 2013 | 43 | 0.020 |
Why?
| | Middle Aged | 2 | 2009 | 34647 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 1997 | 510 | 0.020 |
Why?
| | Microtubules | 1 | 1995 | 286 | 0.020 |
Why?
| | CD24 Antigen | 1 | 2012 | 19 | 0.020 |
Why?
| | Tissue Distribution | 1 | 1993 | 330 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 372 | 0.020 |
Why?
| | Heart Rate | 2 | 2006 | 821 | 0.020 |
Why?
| | Models, Molecular | 2 | 2013 | 1604 | 0.020 |
Why?
| | Macrophages | 1 | 2000 | 1562 | 0.020 |
Why?
| | Haplotypes | 1 | 1994 | 499 | 0.020 |
Why?
| | Young Adult | 1 | 2009 | 13749 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2013 | 600 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2012 | 198 | 0.020 |
Why?
| | Interleukins | 1 | 2013 | 251 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 1995 | 632 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2013 | 378 | 0.020 |
Why?
| | Precipitin Tests | 2 | 2001 | 98 | 0.020 |
Why?
| | Peptides | 2 | 1996 | 979 | 0.020 |
Why?
| | Pichinde virus | 1 | 2010 | 1 | 0.020 |
Why?
| | H-Y Antigen | 1 | 2010 | 7 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 313 | 0.020 |
Why?
| | Mitogens | 1 | 2010 | 59 | 0.020 |
Why?
| | K562 Cells | 1 | 2010 | 95 | 0.020 |
Why?
| | Bystander Effect | 1 | 2010 | 16 | 0.020 |
Why?
| | Autoantibodies | 2 | 2015 | 1475 | 0.020 |
Why?
| | Baculoviridae | 1 | 2010 | 44 | 0.020 |
Why?
| | Cell Polarity | 1 | 2011 | 140 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2010 | 149 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 1989 | 51 | 0.020 |
Why?
| | Genes, fos | 1 | 2009 | 37 | 0.020 |
Why?
| | Proteins | 1 | 1995 | 1015 | 0.020 |
Why?
| | Adolescent | 1 | 2009 | 22130 | 0.020 |
Why?
| | Pseudogenes | 1 | 1988 | 18 | 0.020 |
Why?
| | Blotting, Southern | 1 | 1988 | 75 | 0.020 |
Why?
| | Mycobacterium tuberculosis | 1 | 2012 | 320 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1992 | 447 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2010 | 336 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 1988 | 412 | 0.020 |
Why?
| | Age Factors | 2 | 2012 | 3294 | 0.020 |
Why?
| | MicroRNAs | 1 | 2014 | 692 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2000 | 7923 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 1990 | 625 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1250 | 0.010 |
Why?
| | Models, Cardiovascular | 1 | 2006 | 197 | 0.010 |
Why?
| | Arteries | 1 | 2006 | 262 | 0.010 |
Why?
| | Brain | 1 | 1996 | 2868 | 0.010 |
Why?
| | Lung | 1 | 2016 | 4137 | 0.010 |
Why?
| | Stroke Volume | 1 | 2006 | 590 | 0.010 |
Why?
| | Temperature | 1 | 2006 | 669 | 0.010 |
Why?
| | Subtilisins | 1 | 2001 | 10 | 0.010 |
Why?
| | Aging | 1 | 1993 | 1924 | 0.010 |
Why?
| | Furin | 1 | 2001 | 14 | 0.010 |
Why?
| | Xenopus | 1 | 2001 | 89 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 2001 | 78 | 0.010 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2001 | 43 | 0.010 |
Why?
| | Aged | 1 | 2000 | 24746 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2006 | 1117 | 0.010 |
Why?
| | Cell Aggregation | 1 | 1999 | 25 | 0.010 |
Why?
| | Glycosylphosphatidylinositols | 1 | 1999 | 12 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1999 | 156 | 0.010 |
Why?
| | Lymphoma, T-Cell | 1 | 1999 | 29 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1999 | 77 | 0.010 |
Why?
| | Genes, RAG-1 | 1 | 1998 | 12 | 0.010 |
Why?
| | Hydroxamic Acids | 1 | 1998 | 94 | 0.010 |
Why?
| | Cell Death | 1 | 1999 | 387 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1998 | 114 | 0.010 |
Why?
| | Ectoderm | 1 | 1998 | 53 | 0.010 |
Why?
| | Histone Deacetylases | 1 | 1998 | 210 | 0.010 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 1998 | 211 | 0.010 |
Why?
| | Receptor Aggregation | 1 | 1996 | 11 | 0.010 |
Why?
| | Receptors, Interleukin-4 | 1 | 1996 | 16 | 0.010 |
Why?
| | Immunologic Techniques | 1 | 1996 | 39 | 0.010 |
Why?
| | Janus Kinase 1 | 1 | 1996 | 26 | 0.010 |
Why?
| | Proline | 1 | 1997 | 80 | 0.010 |
Why?
| | Cell Adhesion | 1 | 1998 | 469 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1996 | 196 | 0.010 |
Why?
| | Ovary | 1 | 1998 | 225 | 0.010 |
Why?
| | Vaccines, Synthetic | 1 | 1996 | 139 | 0.010 |
Why?
| | Rosaniline Dyes | 1 | 1995 | 15 | 0.010 |
Why?
| | GRB2 Adaptor Protein | 1 | 1995 | 13 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 1995 | 12 | 0.010 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 46 | 0.010 |
Why?
| | cdc42 GTP-Binding Protein, Saccharomyces cerevisiae | 1 | 1995 | 2 | 0.010 |
Why?
| | Models, Structural | 1 | 1995 | 41 | 0.010 |
Why?
| | Coloring Agents | 1 | 1995 | 96 | 0.010 |
Why?
| | Photochemistry | 1 | 1995 | 133 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 1999 | 1739 | 0.010 |
Why?
| | Chromatin | 1 | 1998 | 533 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1997 | 614 | 0.010 |
Why?
| | Lymphoma, B-Cell | 1 | 1995 | 131 | 0.010 |
Why?
| | Immunization, Passive | 1 | 1994 | 90 | 0.010 |
Why?
| | DNA Methylation | 1 | 1998 | 648 | 0.010 |
Why?
| | Nucleocapsid Proteins | 1 | 1992 | 27 | 0.010 |
Why?
| | Viral Core Proteins | 1 | 1992 | 22 | 0.010 |
Why?
| | Actins | 1 | 1995 | 424 | 0.010 |
Why?
| | Nucleoproteins | 1 | 1992 | 37 | 0.010 |
Why?
| | Escherichia coli | 1 | 1997 | 838 | 0.010 |
Why?
| | ErbB Receptors | 1 | 1995 | 610 | 0.010 |
Why?
| | RNA | 1 | 1998 | 930 | 0.010 |
Why?
| | Immunization | 1 | 1992 | 406 | 0.010 |
Why?
| | Histocompatibility Antigens | 1 | 1989 | 108 | 0.000 |
Why?
|
|
Berg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|